CRA was retained by the claimant in an ICDR dispute in which a multinational pharmaceutical manufacturer alleged breach of contract by a Latin American distribution partner. CRA’s expert report established that selling prices reported by the distribution partner were inaccurate and undermined the partner’s commitment to provide best efforts in its commercialization activities. The quantum assessment included damages due to lost profits and from lost sales opportunities resulting from the respondent’s failures.
Looking ahead to 2026: Trends and expectations for International Arbitration
Across both investor-state and commercial cases, quantum debates have recently turned on attribution under concurrent shocks, the interaction of contract terms...